Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Edwards Lifesciences (EW) Buildings (2023 - 2024)

Historic Buildings for Edwards Lifesciences (EW) over the last 2 years, with Q4 2024 value amounting to $1.3 billion.

Edwards Lifesciences' Buildings rose 1268.29% to $1.3 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 billion, marking a year-over-year increase of 1268.29%. This contributed to the annual value of $1.3 billion for FY2024, which is 1268.29% up from last year.
Latest data reveals that Edwards Lifesciences reported Buildings of $1.3 billion as of Q4 2024, which was up 1268.29% from $1.2 billion recorded in Q4 2023.
Edwards Lifesciences' Buildings' 5-year high stood at $1.3 billion during Q4 2024, with a 5-year trough of $1.2 billion in Q4 2023.